Changes in Pulmonary Hemodynamics Resulted From Long-Term Mechanical Heart Support

Aim      To study the dynamics of right ventricular function and pulmonary hemodynamics in patients with pulmonary hypertension during mechanical circulatory support of the heart.

Material and methods  A retrospective analysis was performed for 25 implantations of left ventricular assist device performed in the Meshalkin National Medical Research Center from 2006 through 2021. Mechanical assist devices were implanted in 21 men and 4 women (median age, 37.5 [29; 48] years). All patients had severe, NYHA functional class III-IV chronic heart failure refractory to the optimal drug therapy. Invasive measurements showed that mean pulmonary arterial pressure (MPAP) was 50 [44.5; 60] mm Hg, transpulmonary pressure gradient (TPG) was 16 [14; 19] mm Hg, and calculated pulmonary vascular resistance was 5.4 [4.9; 9] Wood units, which is an absolute contraindication (TPG >15 mm Hg or pulmonary vascular resistance >5 Wood units) for heart transplantation (HT).

Results Duration of left ventricular support was from 17 to 948 days. For 12 (48 %) patients, the HT was performed at 180-948 days following the implantation of left ventricular assist device; 3 patients are presently waiting for HT; 10 patients died from various complications, 6 of them died during the hospital stage. Already during the early stage after the implantation of the mechanical assist device, pulmonary hemodynamics significantly improved. Thus, in one week, MPAP decreased from 50 [44.5; 60] mm Hg to 36 [33; 38] mm Hg (р=0.012) whereas pulmonary vascular resistance decreased from 5.4 [4.9; 9] to 2.9 [2.4; 3.6] Wood units (р=0.008). Follow-up showed further improvement of pulmonary hemodynamics; at 1 month, MPAP was 29 [27; 30] mm Hg and by the time of HT, MPAP was 2.0 [24.8; 26.3] mm Hg (р=0.01), i.e., reached a normal level, which made it possible to perform HT. Similar dynamics was observed for other variables that reflected pulmonary hemodynamics.

Conclusion      Mechanical support of the heart is able to alleviate manifestations of pulmonary hypertension in most patients with end-stage heart failure. It is necessary to develop an algorithm for identifying the category of patients with a high risk of progression of right ventricular failure.

1. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth Official Adult Heart Transplant Report—2007. The Journal of Heart and Lung Transplantation. 2007;26(8):769–81. DOI: 10.1016/j.healun.2007.06.004

2. Russell SD, Miller LW, Pagani FD. Advanced Heart Failure: A Call to Action. Congestive Heart Failure. 2008;14(6):316–21. DOI: 10.1111/j.1751-7133.2008.00022.x

3. Chernyavskiy A.M., Doronin D.V., Fomichev A.V., Karaskov A.M. The initial experience of implantation of the left ventricular assist device “Sputnik” at a cardiac surgery center. Circulation Pathology and Cardiac Surgery. 2019;23(1):26–32. ]. DOI: 10.21688/1681-3472-2019-1-26-32

4. Elefteriades JA, Lovoulos CJ, Tellides G, Goldstein LJ, Rocco EJ, Condos SG et al. Right ventricle-sparing heart transplant: promising new technique for recipients with pulmonary hypertension. The Annals of Thoracic Surgery. 2000;69(6):1858–63. DOI: 10.1016/S0003-4975(00)01318-7

5. Mareev V.Yu., Ageev F.T., Arutyunov G.P., Koroteev A.V., Mareev Yu.V., Ovchinnikov A.G. et al. SEHF, RSC and RSMSIM national guidelines on CHF diagnostics and treatment (fourth revision) Approved at the SEHF Congress on December 7, 2012, at the SEHF Board of Directors meeting on March 31, 2013, and at the RSC Congress on September 25, 2013. Russian Heart Failure Journal. 2013;14(7):379–472.

6. Costanzo MR, Augustine S, Bourge R, Bristow M, O’Connell JB, Driscoll D et al. Selection and Treatment of Candidates for Heart Transplantation: A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995;92(12):3593–612. DOI: 10.1161/01.CIR.92.12.3593

7. Delgado JF, Gómez-Sánchez MA, Sáenz de la Calzada C, Sánchez V, Escribano P, Hernández-Afonso J et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. The Journal of Heart and Lung Transplantation. 2001;20(9):942–8. DOI: 10.1016/S1053-2498(01)00286-8

8. Kirklin JK, Naftel DC, Bourge RC, McGiffin DC, Hill JA, Rodeheffer RJ et al. Evolving trends in risk profiles and causes of death after heart transplantation: A ten-year multi-institutional study. The Journal of Thoracic and Cardiovascular Surgery. 2003;125(4):881–90. DOI: 10.1067/mtc.2003.168

9. Nedoshivin A.O., Kutuzova A.E., Petrova N.N., Varshavskiy S.Yu., Perepech N.B. Study of the quality of life and psychological state of patients with chronic heart failure. Russian Heart Failure Journal. 2000;1(4):148–59.

10. Aaronson KD, Patel H, Pagani FD. Patient selection for left ventricular assist device therapy. The Annals of Thoracic Surgery. 2003;75(6 Suppl):S29–35. DOI: 10.1016/S0003-4975(03)00461-2

11. Gallagher RC, Kormos RL, Gasior T, Murali S, Griffith BP, Hardesty RL. Univentricular support results in reduction of pulmonary resistance and improved right ventricular function. ASAIO transactions. 1991;37(3):M287-288. PMID: 1751153

12. Andrea G, Giuseppe B, Tiziano C, Maria F, Ettore V. Is fixed severe pulmonary hypertension still a contraindication to heart transplant in the modern era of mechanical circulatory support? A review: Journal of Cardiovascular Medicine. 2008;9(10):1059–62. DOI: 10.2459/JCM.0b013e3282f64249

13. Torre-Amione G, Southard RE, Loebe MM, Youker KA, Bruckner B, Estep JD et al. Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support. The Journal of Heart and Lung Transplantation. 2010;29(2):195–200. DOI: 10.1016/j.healun.2009.05.030

14. Chernyavsky A.M., Doronin D.V., Kornilov I.A., Deryagin M.N., Fomichev A.V., Karaskov A.M. Mechanical heart support in patients with terminal heart failure. Clinical and Experimental Surgery. 2014;2:25–34.

15. Cherniavskiy A.M., Karaskov A.M., Doronin D.V., Deryagin M.N., Fomichev A.V. The results of mechanical heart support systems «IN-COR» implantation. Russian Journal of Transplantology and Artificial Organs. 2014;15(4):84–91. DOI: 10.15825/1995-1191-2013-4-84-91

16. Mikus E, Stepanenko A, Krabatsch T, Loforte A, Dandel M, Lehmkuhl HB et al. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. European Journal of Cardio-Thoracic Surgery. 2011;40(4):971–7. DOI: 10.1016/j.ejcts.2011.01.019

17. Etz CD, Welp HA, Tjan TDT, Hoffmeier A, Weigang E, Scheld HH et al. Medically Refractory Pulmonary Hypertension: Treatment With Nonpulsatile Left Ventricular Assist Devices. The Annals of Thoracic Surgery. 2007;83(5):1697–705. DOI: 10.1016/j.athoracsur.2007.01.019

18. Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. The Journal of Thoracic and Cardiovascular Surgery. 2007;133(3):689–95. DOI: 10.1016/j.jtcvs.2006.08.104

19. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes. The Journal of Thoracic and Cardiovascular Surgery. 2010;139(5):1316–24. DOI: 10.1016/j.jtcvs.2009.11.020

20. Beyersdorf F, Schlensak C, Berchtold-Herz M, Trummer G. Regression of “fixed” pulmonary vascular resistance in heart transplant candidates after unloading with ventricular assist devices. The Journal of Thoracic and Cardiovascular Surgery. 2010;140(4):747–9. DOI: 10.1016/j.jtcvs.2010.05.042

21. Compostella L, Russo N, Setzu T, Compostella C, Bellotto F. Exercise Performance of Chronic Heart Failure Patients in the Early Period of Support by an Axial-Flow Left Ventricular Assist Device as Destination Therapy. Artificial Organs. 2014;38(5):366–73. DOI: 10.1111/aor.12172

22. Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S et al. Risk Factors Predictive of Right Ventricular Failure After Left Ventricular Assist Device Implantation. The American Journal of Cardiology. 2010;105(7):1030–5. DOI: 10.1016/j.amjcard.2009.11.026

23. Potapov EV, Stepanenko A, Dandel M, Kukucka M, Lehmkuhl HB, Weng Y et al. Tricuspid Incompetence and Geometry of the Right Ventricle as Predictors of Right Ventricular Function After Implantation of a Left Ventricular Assist Device. The Journal of Heart and Lung Transplantation. 2008;27(12):1275–81. DOI: 10.1016/j.healun.2008.08.012

24. Mikus E, Stepanenko A, Krabatsch T, Dandel M, Lehmkuhl HB, Loforte A et al. Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making. European Journal of Cardio-Thoracic Surgery. 2011;39(3):310–6. DOI: 10.1016/j.ejcts.2010.05.031

25. Chernyavskiy A.M., Doronin D.V., Fomichev A.V., Osipov D.E., Shmyrev V.A., Karaskov A.M. 10-year heart transplantation experience in Novosibirsk. Russian Journal of Transplantology and Artificial Organs. 2018;20(1):23–31. DOI: 10.15825/1995-1191-2018-1-23-31